Sale!

Fibrinogen from Bovine Plasma Lyophilized

$350.00 $195.00

Catalog #: P2010009 – 100 mg

Fibrinogen is a protein directly involved in blood clotting through its proteolysis into fibrin after action of the protease thrombin. Fibrinogens from various mammalian species typically cross-react with each other when it comes to activation with thrombin.

Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am – 8 pm PST)

In stock

SKU: P2010009 Category:

Description

Fibrinogen from Bovine Plasma

Product Data Sheet Download PDF
MSDS Download PDF
Catalog number: P2010009
Lot number: 0119P0009
Expiration date: 4/6/23
Package Size: 100 mg
Synonym: Factor I
Molecular Weight: 340 kDa
Appearance: Lyophilized powder
Storage: -20°C or lower. Avoid repeated freeze-thaw.
purity: >95%
Source: Bovine plasma
Recommended buffer: 0.9% NaCl at 37 °C.

 

References

  • Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020 Apr 23.
  • Santos AS, Oliveira AJF, Barbosa MCL, Nogueira JLDS. Viscoelastic haemostatic assays in the perioperative period of surgical procedures: Systematic review and meta-analysis. J Clin Anesth. 2020 Apr 13;64:109809.
  • Rehiman SH, Lim SM, Neoh CF, Majeed ABA, Chin AV, Tan MP, Kamaruzzaman SB, Ramasamy K. Proteomics as a reliable approach for discovery of blood-based Alzheimer’s disease biomarkers: a systematic review and meta-analysis. Ageing Res Rev. 2020 Apr 12:101066.
  • Solaimanzadeh I. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19). Cureus. 2020 Mar 20;12(3):e7343.
  • Valade S, Mariotte E, Azoulay E. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Crit Care Clin. 2020 Apr;36(2):415-426.
  • Ciftciler R, Ciftciler AE, Malkan UY, Haznedaroglu IC. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper). SAGE Open Med. 2020 Feb 16;8:2050312120907811.
  • Zhou J, Lu Y, Wang S, Chen K. Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies. Inflamm Res. 2020 Apr;69(4):331-345.
  • Steinbicker AU, Wittenmeier E, Goobie SM. Pediatric non-red cell blood product transfusion practices: what’s the evidence to guide transfusion of the ‘yellow’ blood products? Curr Opin Anaesthesiol. 2020 Apr;33(2):259-267.
  • Zaidi A, Kohli R, Daru J, Estcourt L, Khan KS, Thangaratinam S, Green L. Early Use of Fibrinogen Replacement Therapy in Postpartum Hemorrhage-A Systematic Review. Transfus Med Rev. 2020 Jan 28. pii: S0887-7963(20)30009-2.